AdaptHealth (NASDAQ:AHCO – Get Rating) had its price objective hoisted by Truist Financial from $26.00 to $28.00 in a research report sent to investors on Monday morning, The Fly reports. The brokerage currently has a buy rating on the stock.
Several other research analysts have also recently weighed in on the stock. TheStreet raised shares of AdaptHealth from a d+ rating to a c- rating in a research report on Tuesday, August 2nd. SVB Leerink upped their target price on shares of AdaptHealth from $24.00 to $29.00 and gave the company an outperform rating in a research report on Wednesday, August 10th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of AdaptHealth from $22.00 to $26.00 in a research report on Wednesday, August 10th. Four investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of Buy and a consensus target price of $26.83.
AdaptHealth Trading Up 9.8 %
Shares of AHCO stock opened at $22.12 on Monday. The company’s 50-day moving average price is $20.86 and its 200-day moving average price is $18.05. The company has a current ratio of 1.39, a quick ratio of 1.15 and a debt-to-equity ratio of 1.02. The stock has a market cap of $2.97 billion, a price-to-earnings ratio of 42.54, a PEG ratio of 0.32 and a beta of 0.59. AdaptHealth has a twelve month low of $11.40 and a twelve month high of $28.75.
Insider Transactions at AdaptHealth
In other news, General Counsel Christopher J. Joyce sold 100,000 shares of the stock in a transaction dated Tuesday, August 16th. The shares were sold at an average price of $22.20, for a total transaction of $2,220,000.00. Following the sale, the general counsel now owns 106,071 shares of the company’s stock, valued at $2,354,776.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, major shareholder Everest Hill Group Inc. sold 215,382 shares of the company’s stock in a transaction that occurred on Friday, August 12th. The shares were sold at an average price of $23.50, for a total transaction of $5,061,477.00. Following the sale, the insider now directly owns 15,119,834 shares in the company, valued at $355,316,099. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Christopher J. Joyce sold 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $22.20, for a total transaction of $2,220,000.00. Following the sale, the general counsel now owns 106,071 shares in the company, valued at $2,354,776.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 474,382 shares of company stock valued at $10,938,477. 17.29% of the stock is currently owned by corporate insiders.
Institutional Trading of AdaptHealth
A number of large investors have recently made changes to their positions in AHCO. Advisor Group Holdings Inc. increased its stake in shares of AdaptHealth by 306.5% during the fourth quarter. Advisor Group Holdings Inc. now owns 3,000 shares of the company’s stock worth $73,000 after buying an additional 2,262 shares during the period. Teacher Retirement System of Texas increased its stake in shares of AdaptHealth by 26.6% during the fourth quarter. Teacher Retirement System of Texas now owns 15,270 shares of the company’s stock worth $374,000 after buying an additional 3,209 shares during the period. Rhumbline Advisers increased its stake in AdaptHealth by 0.6% in the fourth quarter. Rhumbline Advisers now owns 101,502 shares of the company’s stock valued at $2,483,000 after purchasing an additional 593 shares during the last quarter. Covestor Ltd purchased a new position in AdaptHealth in the fourth quarter valued at approximately $35,000. Finally, Ensign Peak Advisors Inc purchased a new position in AdaptHealth in the fourth quarter valued at approximately $302,000. 75.76% of the stock is currently owned by hedge funds and other institutional investors.
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
- Get a free copy of the StockNews.com research report on AdaptHealth (AHCO)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.